Besides, we showed that the T allele of MTHFRC677T polymorphism influenced the Hcy level which is an independent risk factor for HHC in Tunisian BD patients.
Evidence suggests that mutations in methylenetetrahydrofolate reductase (MTHFR) appear to be linked with hyperhomocysteinemia (HHC) and cerebral-thrombotic events in children.